Latest updates for Aml
Fresh curated links around AML are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Amyloidosis Continues To Fight Back
- The tough task of reversing cardiac Amyloidosis : Classification of “Anti-Amyloid”drugs
- Lilly’s Newly Acquired Drug Shows Promise as Next-Gen Blood Cancer Med
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The tough task of reversing cardiac Amyloidosis : Classification of “Anti-Amyloid”drugs
Amyloidosis is a proteostatic disease , meaning a progressive disorder of extracellular deposition of insoluble protein fibrils in tissues.It affects , brain, kidney, nerves and al...
Lilly’s Newly Acquired Drug Shows Promise as Next-Gen Blood Cancer Med
Eli Lilly presented encouraging Phase 1 results for AJ1-11095 at the European Hematology Association (EHA) annual meeting in Stockholm. The drug, a type II JAK2 inhibitor in develo...
Pre-Amyloidosis Red-Flag Clinical Diagnoses in Light Chain (AL) Versus Age-Related Transthyretin (ATTRwt) Amyloidosis: E...
This electronic health record–based study highlights distinct diagnostic patterns preceding a diagnosis of light chain (AL) and wild-type transthyretin (ATTRwt) amyloidosis; AL amy...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.